Growth Metrics

Innoviva (INVA) Gross Margin (2011 - 2026)

Innoviva posted quarterly Gross Margin of 77.39% for Q1 2026, down 533.0% year-on-year from 17.87% in Q1 2025, and up 10.43% on a QoQ basis from 70.07% in Q3 2025.

Innoviva (INVA) has 9 years of Gross Margin data on file, last reported at 77.39% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin fell 533.0% year-over-year to 77.39%; the trailing twelve-month figure through Mar 2026 stood at 100.22% (down 412.0% YoY), and the FY2025 full-year result was 74.8%, down 778.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 77.39%, up from 70.07% in the prior quarter.
  • Across five years, Gross Margin topped out at 6220.29% in Q1 2024 and bottomed at 816.22% in Q2 2023.
  • The 5-year median for Gross Margin is 82.91% (2025), against an average of 475.6%.
  • The widest annual swing landed in 2024, when Gross Margin surged 632129 bps; it then slumped 613757 bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 100.0% in 2022, then changed by 0 bps to 100.0% in 2023, then slipped by 18 bps to 81.56% in 2024, then slipped by 14 bps to 70.07% in 2025, then gained by 10 bps to 77.39% in 2026.
  • The last three Gross Margin figures came in at 77.39% (Q1 2026), 70.07% (Q3 2025), and 82.91% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 79.04%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 86.85%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 91.79%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 82.22%
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn 77.39%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 77.39%
Sep 30, 2025 70.07%
Jun 30, 2025 82.91%
Mar 31, 2025 82.72%
Sep 30, 2024 81.56%
Jun 30, 2024 85.07%
Mar 31, 2024 6,220.29%
Sep 30, 2023 100.00%
Jun 30, 2023 -816.22%
Mar 31, 2023 -101.01%
Sep 30, 2022 100.00%
Jun 30, 2022 100.00%
Mar 31, 2022 100.00%
Sep 30, 2021 100.00%
Mar 31, 2014 75.90%
Mar 31, 2013 100.00%
Dec 31, 2011 100.00%
Sep 30, 2011 100.00%
Jun 30, 2011 81.58%